We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Zonder doelen of dossiers

    Eva Prins in Zorg + Welzijn
    Article 26 May 2023
  2. Enticing Local Governments to Produce FAIR Freedom of Information Act Dossiers

    Government transparency is central in a democratic society, and increasingly governments at all levels are required to publish records and data...
    Maarten Marx, Maik Larooij, ... Jaap Kamps in Advances in Information Retrieval
    Conference paper 2023
  3. Implementation of Quality by Design (QbD) Principles in Regulatory Dossiers of Medicinal Products in the European Union (EU) Between 2014 and 2019

    Background

    Quality by Design (QbD) is a systematic risk-based approach to development, with predefined characteristics and quality risk management...

    Judith P. ter Horst, Sada L. Turimella, ... Alex Zwiers in Therapeutic Innovation & Regulatory Science
    Article Open access 13 January 2021
  4. Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study

    Background

    The popular use of herbal medicines necessitates national regulatory authorities to have efficient mechanisms for the control of these...

    Alambo K. Mssusa, Lone Holst, ... Sheila Maregesi in Journal of Pharmaceutical Policy and Practice
    Article Open access 20 November 2023
  5. Sha** a suitable EU HTA dossier template: why the German template is not fit for purpose

    From 2025, Health Technology Developers (HTDs) have to submit EU HTA dossiers. The joint clinical assessment (JCA) aims to streamline HTA processes...

    Maria Katharina Schweitzer, Manuel Nico Dold, ... Sebastian Werner in The European Journal of Health Economics
    Article Open access 16 October 2023
  6. Socio-economic analysis in REACH restriction dossiers for chemicals management: A critical review

    This paper offers a critical review of socio-economic analysis (SEA) in Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)...

    Silke Gabbert, Isabel Hilber in Ambio
    Article Open access 05 December 2019
  7. Dossier Novels: The Reader as Detective

    This chapter examines lists in the context of dossier novels and uses Charles Warren Adams’s The Notting Hill Mystery (1865) and the Murder Dossier...
    Chapter Open access 2023
  8. Defence of Biocidal Active Substance Dossiers in the Context of Regulatory Toxicology

    In this chapter, the expertise gathered in the broad area of toxicology and its implementation into the regulatory context is illustrated using the...
    Michael Werner in Regulatory Toxicology
    Living reference work entry 2021
  9. Defence of Biocidal Active Substance Dossiers in the Context of Regulatory Toxicology

    In this chapter, the expertise gathered in the broad area of toxicology and its implementation into the regulatory context is illustrated using the...
    Michael Werner in Regulatory Toxicology
    Reference work entry 2021
  10. Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?

    Background

    Information on drug safety in different ethnic populations reported in public documents such as the European Public Assessment Reports...

    Marc Maliepaard, Anne C. Taams, ... Yang Yu in Pharmaceutical Medicine
    Article Open access 05 September 2019
  11. Una muestra bibliográfica [A Bibliographic Sampling] of Latin American Digital Poetry (So Far)

    This bibliography is composed of key dossiers, edited books, monographs, and special journal issues, all of which represent important touchstones in...
    Scott Weintraub in Latin American Digital Poetics
    Chapter 2024
  12. Data in CIB

    This chapter addresses the three fundamental data objects needed for CIB analysis: descriptors, descriptor variants, and cross-impact data. The basic...
    Chapter 2023
  13. Role of Economic Evaluations on Pricing of Medicines Reimbursed by the Italian National Health Service

    Objective

    The main objective of this study was to explore the extent to which the incremental cost-effectiveness ratio (ICER), alongside other...

    Pierluigi Russo, Matteo Zanuzzi, ... Andrea Manca in PharmacoEconomics
    Article Open access 25 November 2022
  14. Non-disclosure of developmental neurotoxicity studies obstructs the safety assessment of pesticides in the European Union

    Background

    In the European Union (EU), the safety assessment of plant protection products relies to a large extent on toxicity studies commissioned by...

    Axel Mie, Christina Rudén in Environmental Health
    Article Open access 01 June 2023
  15. Career Opportunities in Toxicology

    In Chap. 4 , an overview is given of the career opportunities for toxicologists in the pharmaceutical...
    Chapter 2023
  16. State of the practice of health information systems: a survey study amongst health care professionals in intellectual disability care

    Background

    Care for people with an Intellectual Disability (ID) is complex: multiple health care professionals are involved and use different Health...

    Joep Tummers, Hilde Tobi, ... Geraline Leusink in BMC Health Services Research
    Article Open access 18 November 2021
  17. Huiselijk geweld (inclusief kindermishandeling)

    Bij vermoedens van geweld en onveiligheid voor kinderen is er de wettelijke plicht de meldcode te hanteren. Deze is doorlopend aan ontwikkeling...
    V. W. van den Bergh, L. Vogtländer, ... W. M. Tempelaar in Acute psychiatrie
    Chapter 2022
  18. KI-gestütztes Recruiting – technische Grundlagen, wirtschaftliche Chancen und Risiken sowie ethische und soziale Herausforderungen

    When recruiting new employees, companies today increasingly rely on the support of artificial intelligence (AI). The technical possibilities range...

    Gwendolin Wilke, Oliver Bendel in HMD Praxis der Wirtschaftsinformatik
    Article Open access 07 March 2022
  19. 10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?

    Objectives

    The German Pharmaceutical Market Restructuring Act (AMNOG, 2011) is a two-stage process to regulate the price of new pharmaceuticals in...

    Melanie Büssgen, Tom Stargardt in Applied Health Economics and Health Policy
    Article Open access 30 May 2023
  20. Der Lernmanager als post-panoptische Kommunikationsplattform

    Die Digitalisierung bietet neue technische Möglichkeiten zur Individualisierung des Unterrichts. Während die Entwicklung von Lernsoftware das...
    Judith Hangartner, Laura Weidmann, Regula Fankhauser in Praxistheoretische Perspektiven auf Schule in der Kultur der Digitalität
    Chapter 2022
Did you find what you were looking for? Share feedback.